Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
NPJ Parkinson'S Disease|April 24, 2023
CSF neurochemical profile and cognitive changes in Parkinson's disease with mild cognitive impairmentFederico Paolini Paoletti, Lorenzo Gaetani, Giovanni Bellomo, et al.
Journal of Neurology|September 24, 2025
Effect of aging on biomarkers and clinical profile in Parkinson's diseaseGiulia Di Lazzaro, Federico Paolini Paoletti, Giovanni Bellomo, et al.
NPJ Parkinson'S Disease|August 7, 2025
Phosphorylated α-synuclein in CSF and plasma does not reflect synucleinopathyGiovanni Bellomo, Erik Stoops, Jeroen Vanbrabant, et al.
Journal of Alzheimer'S Disease : JAD|September 19, 2022
A Combination of Neurofilament Light, Glial Fibrillary Acidic Protein, and Neuronal Pentraxin-2 Discriminates Between Frontotemporal Dementia and Other DementiasKatharina Bolsewig, Yanaika S Hok-A-Hin, Federica N Sepe, et al.
Antioxidants (Basel, Switzerland)|August 28, 2025
Diet-Derived Advanced Glycation End-Products (AGEs) Induce Muscle Wasting In Vitro, and a Standardized Vaccinium macrocarpon Extract Restrains AGE Formation and AGE-Dependent C2C12 Myotube AtrophyMartina Paiella, Tommaso Raiteri, Simone Reano, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 7, 2024
Fully automated measurement of plasma Aβ42/40 and p-tau181: Analytical robustness and concordance with cerebrospinal fluid profile along the Alzheimer's disease continuum in two independent cohortsGiovanni Bellomo, Sherif Bayoumy, Alfredo Megaro, et al.
Molecular Neurodegeneration|April 3, 2023
Cerebrospinal fluid lipoproteins inhibit α-synuclein aggregation by interacting with oligomeric species in seed amplification assaysGiovanni Bellomo, Silvia Paciotti, Luis Concha-Marambio, et al.
NPJ Parkinson'S Disease|November 30, 2024
Molecular and cellular determinants of L-Dopa-induced dyskinesia in Parkinson's DiseaseFederica Servillo, Maria De Carluccio, Giulia Di Lazzaro, et al.
Clinical Chemistry and Laboratory Medicine|November 13, 2021
Validation of the LUMIPULSE automated immunoassay for the measurement of core AD biomarkers in cerebrospinal fluidJohan Gobom, Lucilla Parnetti, Pedro Rosa-Neto, et al.
Molecular & Cellular Proteomics : MCP|August 9, 2023
Methods to Discover and Validate Biofluid-Based Biomarkers in Neurodegenerative DementiasCharlotte E Teunissen, Leighann Kimble, Sherif Bayoumy, et al.
Pageof 6